Administered By

• Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

• Memorial Sloan-Kettering Cancer Center 

Contributors

• Rizzieri, David Alan Principal Investigator

Start/End

• May 1, 2017 - April 30, 2020